Merus B.V.

Merus is a biotechnology company that is applying its proprietary technologies to build a pipeline of innovative human therapeutic antibodies. These technologies support the generation of innovative antibody formats for improved clinical efficacy, e.g. bispecific antibodies or mixtures of antibodies. Merus aims to demonstrate superior efficacy of these human, recombinant, antibody-based therapeutics in relevant preclinical models and further develop selected product candidates through early clinical testing in multiple therapeutic areas.